Schedule 13D ownership disclosure

TRANSCODE THERAPEUTICS INC

Common Stock · CUSIP: 89357L501

Event date: 2025-10-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • CK Life Sciences Int'l., (Holdings) Inc.Reported CIK 0001297567

    Shares: 83,285.00 · Class: 9.1%

  • DEFJ, LLC

    Shares: 83,285.00 · Class: 9.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-103292
Form type
SCHEDULE 13D/A
Filer
CK Life Sciences Intl (Holdings) Inc
CIK
CIK 1297567
Filed
Oct 28, 2025
Reporting period
Oct 27, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub